MedPath

Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients

Not Applicable
Completed
Conditions
Glycerin Cryopreserved Acellular Corneal Tissue
Deep Anterior Lamellar Keratoplasty
High Risk Keratoplasty
Interventions
Procedure: DALK using GCCT
Procedure: DALK using FCT
Registration Number
NCT01021046
Lead Sponsor
Wenzhou Medical University
Brief Summary

The purpose of this study is to study whether deep anterior lamellar keratoplasty (DALK) using acellular tissue will promote corneal graft survival in high risk patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
78
Inclusion Criteria
  • severe bacterial keratitis
  • Herpes simplex keratitis
  • severe fungal keratitis
  • partial limbal deficiency after chemical burn
Exclusion Criteria
  • posterior stroma involved in severe bacterial and fungal keratitis
  • dry eye
  • glaucoma or intraocular pressure greater than 21 mmHg
  • amblyopia
  • retinal abnormalities
  • patients with severe systemic diseases not good for ocular surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GCCT,corneal allograft survival ,DALKDALK using GCCTexperimental group: deep anterior lamellar keratoplasty using glycerin-cryopreserved corneal tissue
FCT,corneal allograft survival ,DALKDALK using FCTcontrol group: deep anterior lamellar keratoplasty using fresh corneal tissue
Primary Outcome Measures
NameTimeMethod
rejection
Secondary Outcome Measures
NameTimeMethod
laser scanning in vivo confocal microscopy

Trial Locations

Locations (1)

Eye Hospital, Wenzhou Medical College

🇨🇳

Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath